Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D02FHX
|
|||
| Former ID |
DNC011976
|
|||
| Drug Name |
4-Ethyl-oxazolidin-(2Z)-ylideneamine
|
|||
| Synonyms |
CHEMBL108788; 4-Ethyl-oxazolidin-(2Z)-ylideneamine; 4-Ethyloxazolidine-2-imine; SCHEMBL10211233; BDBM50138188; AKOS013533141
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C5H10N2O
|
|||
| Canonical SMILES |
CCC1COC(=N1)N
|
|||
| InChI |
1S/C5H10N2O/c1-2-4-3-8-5(6)7-4/h4H,2-3H2,1H3,(H2,6,7)
|
|||
| InChIKey |
JTEWXLMHFCOPAX-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | 4,5-Disubstituted-1,3-oxazolidin-2-imine derivatives: a new class of orally bioavailable nitric oxide synthase inhibitor. Bioorg Med Chem Lett. 2004 Jan 19;14(2):313-6. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.